Development of digital PCR‑based‑products to test for cancer‑related gene mutations

In this dynamic session, we discuss how digital PCR (dPCR) is a key technology in cancer research for cancer-associated mutation detection. Dr. Hong reveals how IDT’s advanced products are driving innovations in dPCR technology, transforming the landscape of cancer mutation detection. Learn more at https://idtb.io/jkh49g